|
1
|
Docherty HM, Hay CW, Ferguson LA, Barrow
J, Durward E and Docherty K: Relative contribution of PDX-1, MafA
and E47/beta2 to the regulation of the human insulin promoter.
Biochem J. 389:813–820. 2005. View Article : Google Scholar :
|
|
2
|
Olbrot M, Rud J, Moss LG and Sharma A:
Identification of beta-cell-specific insulin gene transcription
factor RIPE3b1 as mammalian MafA. In: Proc Natl Acad Sci USA. 99.
pp. 6737–6742. 2002; View Article : Google Scholar :
|
|
3
|
Zhang C, Moriguchi T, Kajihara M, Esaki R,
Harada A, Shimohata H, Oishi H, Hamada M, Morito N, Hasegawa K, et
al: MafA is a key regulator of glucose-stimulated insulin
secretion. Mol Cell Biol. 25:4969–4976. 2005. View Article : Google Scholar :
|
|
4
|
Matsuoka TA, Kaneto H, Stein R, Miyatsuka
T, Kawamori D, Henderson E, Kojima I, Matsuhisa M, Hori M and
Yamasaki Y: MafA regulates expression of genes important to islet
beta-cell function. Mol Endocrinol. 21:2764–2774. 2007. View Article : Google Scholar
|
|
5
|
Schwarze SR and Dowdy SF: In vivo protein
transduction: Intracellular delivery of biologically active
proteins, compounds and DNA. Trends Pharmacol Sci. 21:45–48. 2000.
View Article : Google Scholar
|
|
6
|
Ho A, Schwarze SR, Mermelstein SJ, Waksman
G and Dowdy SF: Synthetic protein transduction domains: Enhanced
transduction potential in vitro and in vivo. Cancer Res.
61:474–477. 2001.
|
|
7
|
Matsushita M, Tomizawa K, Moriwaki A, Li
ST, Terada H and Matsui H: A high-efficiency protein transduction
system demonstrating the role of PKA in long-lasting long-term
potentiation. J Neurosci. 21:6000–6007. 2001.
|
|
8
|
Matsui H, Tomizawa K, Lu YF and Matsushita
M: Protein, Therapy: In vivo protein transduction by polyarginine
(11R) PTD and subcellular targeting delivery. Curr Protein Pept
Sci. 4:151–157. 2003. View Article : Google Scholar
|
|
9
|
Kim D, Kim CH, Moon JI, Chung YG, Chang
MY, Han BS, Ko S, Yang E, Cha KY, Lanza R and Kim KS: Generation of
human induced pluripotent stem cells by direct delivery of
reprogramming proteins. Cell Stem Cell. 4:472–476. 2009. View Article : Google Scholar :
|
|
10
|
Zhang H, Ma Y, Gu J, Liao B, Li J, Wong J
and Jin Y: Reprogramming of somatic cells via TAT-mediated protein
transduction of recombinant factors. Biomaterials. 33:5047–5055.
2012. View Article : Google Scholar
|
|
11
|
Kaneto H, Matsuoka TA, Nakatani Y,
Miyatsuka T, Matsuhisa M, Hori M and Yamasaki Y: A crucial role of
MafA as a novel therapeutic target for diabetes. J Biol Chem.
280:15047–15052. 2005. View Article : Google Scholar
|
|
12
|
Nomura S, Nakamura T, Hashimoto T, Nishio
Y, Maegawa H, Kudo M and Kashiwagi A: MafA differentiates rat
intestinal cells into insulin-producing cells. Biochem Biophys Res
Commun. 349:136–143. 2006. View Article : Google Scholar
|
|
13
|
Schonhoff SE, Giel-Moloney M and Leiter
AB: Minireview: Development and differentiation of gut endocrine
cells. Endocrinology. 145:2639–2644. 2004. View Article : Google Scholar
|
|
14
|
van der Flier LG and Clevers H: Stem
cells, self-renewal, and differentiation in the intestinal
epithelium. Annu Rev Physiol. 71:241–260. 2009. View Article : Google Scholar
|
|
15
|
Wu KK and Huan Y: Streptozotocin-induced
diabetic models in mice and rats. Curr Protoc Pharmacol Chapter.
5:Unit 5.47. 2008. View Article : Google Scholar
|
|
16
|
Lu J, Li G, Lan MS, Zhang S, Fan W, Wang H
and Lu D: Pax4 paired domain mediates direct protein transduction
into mammalian cells. Endocrinology. 148:5558–5565. 2007.
View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Zacharakis G, Kambara H, Shih H, Ripoll J,
Grimm J, Saeki Y, Weissleder R and Ntziachristos V: Volumetric
tomography of fluorescent proteins through small animals in vivo.
In: Proc Natl Acad Sci USA. 102. pp. 18252–18257. 2005; View Article : Google Scholar :
|
|
19
|
Toro A and Grunebaum E: TAT-mediated
intracellular delivery of purine nucleoside phosphorylase corrects
its deficiency in mice. J Clin Invest. 116:2717–2726. 2006.
View Article : Google Scholar :
|
|
20
|
Yamada S, Kanno H and Kawahara N:
Trans-membrane peptide therapy for malignant glioma by use of a
peptide derived from the MDM2 binding site of p53. J Neurooncol.
109:7–14. 2012. View Article : Google Scholar
|
|
21
|
Slack JM: Developmental biology of the
pancreas. Development. 121:1569–1580. 1995.
|
|
22
|
Grapin-Botton A, Majithia AR and Melton
DA: Key events of pancreas formation are triggered in gut endoderm
by ectopic expression of pancreatic regulatory genes. Genes Dev.
15:444–454. 2001. View Article : Google Scholar :
|
|
23
|
Jenny M, Uhl C, Roche C, Duluc I,
Guillermin V, Guillemot F, Jensen J, Kedinger M and Gradwohl G:
Neurogenin3 is differentially required for endocrine cell fate
specification in the intestinal and gastric epithelium. EMBO J.
21:6338–6347. 2002. View Article : Google Scholar :
|
|
24
|
Kojima H, Fujimiya M, Matsumura K, Younan
P, Imaeda H, Maeda M and Chan L: NeuroD-betacellulin gene therapy
induces islet neogenesis in the liver and reverses diabetes in
mice. Nat Med. 9:596–603. 2003. View
Article : Google Scholar
|
|
25
|
Taniguchi H, Yamato E, Tashiro F, Ikegami
H, Ogihara T and Miyazaki J: beta-cell neogenesis induced by
adenovirus-mediated gene delivery of transcription factor pdx-1
into mouse pancreas. Gene Ther. 10:15–23. 2003. View Article : Google Scholar
|
|
26
|
Kaneto H, Matsuoka TA, Katakami N and
Matsuhisa M: Combination of MafA, PDX-1 and NeuroD is a useful tool
to efficiently induce insulin-producing surrogate beta-cells. Curr
Med Chem. 16:3144–3151. 2009. View Article : Google Scholar
|
|
27
|
Wang AY, Ehrhardt A, Xu H and Kay MA:
Adenovirus transduction is required for the correction of diabetes
using Pdx-1 or Neurogenin-3 in the liver. Mol Ther. 15:255–263.
2007. View Article : Google Scholar
|
